Bauya, Jaime S.

HRN: 28-69-76  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/17/2026
03/24/2026
IV
4.5g Loading Dose Then 2.5g
Q 8
UGIB With Leukocytosis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: